Response Letter to the “ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment”

Abstract

Get full access to this article

View all access options for this article.

References

P.K.

, Szeto

C.C.

, Piraino

, De Arteaga

, Fan

, Figueiredo

A.E.

ISPD peritonitis recommendations: 2016 update on prevention and treatment.

Perit Dial Int 2016; 36(5): 481–508.

P.K.

, Szeto

C.C.

, Piraino

, Bernardini

, Figueiredo

A.E.

, Gupta

Peritoneal dialysis-related infections recommendations: 2010 update.

Perit Dial Int 2010; 30(4): 393–423.

Anwar

, Merchant

, Were

, Tooth

, Uttley

, Gokal

A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.

Perit Dial Int 1995; 15(2): 167–71.

Leung

C.B.

, Szeto

C.C.

, Chow

K.M.

, Kwan

B.C.

, Wang

A.Y.

, Lui

S.F.

Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis—a randomized controlled trial.

Perit Dial Int 2004; 24(5): 440–6.

Craig

W.A.

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Clin Infect Dis 1998; 26(1): 1–10.

Falagas

M.E.

, Tansarli

G.S.

, Ikawa

, Vardakas

K.Z.

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.

Clin Infect Dis 2013; 56(2): 272–82.

Deslandes

, Gregoire

, Bouquie

, Le

M.A.

, Allard

, Dailly

Stability and compatibility of antibiotics in peritoneal dialysis solutions applied to automated peritoneal dialysis in the pediatric population.

Perit Dial Int 2016; 36(6): 676–9.

Turnidge

J.D.

The pharmacodynamics of beta-lactams.

Clin Infect Dis 1998; 27(1): 10–22.